PLG and myeloid sarcoma: The presence of anti-NR2 antibodies in MS patients was less associated with anti-plasmin IgG antibodies [OR:0.96 (95%CI: 0.92-0.99); <i>p</i> < 0.05]; however, such an association was not demonstrated when analyzing only RRMS patients.